In today’s dish, a clinical-stage biotech company is set to go public through a SPAC. Also, a SPAC signs a letter of intent to take the subsidiaries of a biotech compan…
© 2024 Bill SPACman 📈
Substack is the home for great culture
In today’s dish, a clinical-stage biotech company is set to go public through a SPAC. Also, a SPAC signs a letter of intent to take the subsidiaries of a biotech compan…